US BROKER MOVES: IP upgraded at JPM; XOM downgraded at BofA

UPGRADES Bancolombia (CIB) Upgraded to Buy from Neutral at Goldman Sachs; PT USD 98 (prev USD 81) Gossamer Bio (GOSS) Upgraded to Outperform from Market Perform at Leerink; PT USD 1 Honeywell (HON) Upgraded to Neutral from Underperform at BofA Securities; PT USD 265 (prev USD 205) International Paper (IP) Upgraded to Overweight from Neutral at JPMorgan; PT USD 61 (prev USD 51) Medtronic (MDT) Upgraded to Buy from Neutral at UBS; PT USD 100 Magnolia Oil & Gas (MGY) Upgraded to Buy from Hold at Truist Securities; PT USD 33 Nutrien (NTR) Upgraded to Outperform from Neutral at BNP Paribas Exane; PT USD 80 Richardson Electronics (RELL) Upgraded to Outperform from Market Perform at Northland; PT USD 24 Solventum (SOLV) Upgraded to Buy from Neutral at UBS; PT USD 95 DOWNGRADES Albertsons (ACI) Downgraded to Neutral from Buy at UBS; PT USD 12 (prev USD 20) Bank of Marin Bancorp (BMRC) Downgraded to Neutral from Buy at Brean Capital Capricor Therapeutics (CAPR) Downgraded to Neutral from Buy at Alliance Global Partners Clorox (CLX) Downgraded to Hold from Buy at Jefferies; PT USD 98 (prev USD 125) Crinetics Pharmaceuticals (CRNX) Downgraded to Neutral from Buy at UBS; PT USD 85 (prev USD 55) Eastern Bankshares (EBC) Downgraded to Equal Weight from Overweight at Stephens Forte Biosciences (FBRX) Downgraded to Equal Weight from Overweight at Barclays; PT USD 77 (prev USD 74) Fresenius Medical Care (FMS) Downgraded to Underperform from Neutral at BNP Paribas Exane; PT USD 19.90 Intuit (INTU) Downgraded to Hold from Buy at TD Cowen; PT USD 304 (prev USD 504) Levi Strauss (LEVI) Downgraded to Equal Weight from Overweight at Wells Fargo; PT USD 25 Progyny (PGNY) Downgraded to Equal Weight from Overweight at Barclays; PT USD 34 (prev USD 27) Alpine Income Property Trust (PINE) Downgraded to Outperform from Strong Buy at Raymond James; PT USD 22 Procept BioRobotics (PRCT) Downgraded to Neutral from Buy at UBS RXO (RXO) Downgraded to Sell from Hold at TD Cowen; PT USD 19 (prev USD 24) Selective Insurance Group (SIGI) Downgraded to Market Perform from Outperform at BMO Capital; PT USD 97 Exxon Mobil (XOM) Downgraded to Neutral from Buy at BofA Securities; PT USD 158 (prev USD 154) INITIATIONS Alphatec Holdings (ATEC) Initiated Buy at UBS; PT USD 15 Anterix (ATEX) Initiated Buy at Clear Street; PT USD 161 Becton Dickinson (BDX) Initiated Buy at UBS; PT USD 190 Bausch + Lomb (BLCO) Initiated Buy at UBS Benitec Biopharma (BNTC) Initiated Outperform at Wedbush; PT USD 16 Cooper Companies (COO) Initiated Neutral at UBS; PT USD 75 Edwards Lifesciences (EW) Initiated Buy at UBS; PT USD 110 Glaukos (GKOS) Initiated Neutral at UBS Globus Medical (GMED) Initiated Neutral at UBS; PT USD 82 GXO Logistics (GXO) Initiated Overweight at Wells Fargo; PT USD 18 Integra LifeSciences (IART) Initiated Neutral at UBS; PT USD 19 Inspire Medical Systems (INSP) Initiated Sell at UBS; PT USD 39 Intuitive Surgical (ISRG) Initiated Buy at UBS; PT USD 500 Kodiak Gas Services (KGS) Initiated Overweight at Piper Sandler; PT USD 78 Insulet (PODD) Initiated Neutral at UBS; PT USD 174 Silvergate Capital (SI) Initiated Buy at UBS; PT USD 27 SI-BONE (SIBN) Initiated Buy at UBS; PT USD 24 STAAR Surgical (STAA) Initiated Sell at UBS; PT USD 20 STERIS (STE) Initiated Buy at UBS; PT USD 275 Stryker (SYK) Initiated Buy at UBS; PT USD 400 Tenax Therapeutics (TENX) Initiated Buy at Canaccord; PT USD 35 Teleflex (TFX) Initiated Neutral at UBS; PT USD 145 TransMedics Group (TMDX) Initiated Neutral at UBS; PT USD 80 Zimmer Biomet (ZBH) Initiated Buy at UBS